Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Iverson Genetic Diagnostics signs diagnostic commercialization agreement with Johns Hopkins

Oct. 15, 2012

DKFZ and Genetic Immunity to collaborate on development of therapeutic vaccine against HPV

Oct. 15, 2012

Canadian commercialization agreement set for MoxDuo

Oct. 11, 2012

Crucell signs agreement to use Mucosis' platform for vaccine program

Oct. 11, 2012

Aeras and GSK enter agreement on tuberculosis vaccine development

Oct. 11, 2012

MedImmune enters immunotherapy collaboration with cancer organizations

Oct. 10, 2012

Sanofi and Massachusetts General Hospital enter 2-year oncology collaboration

Oct. 10, 2012

Ajinomoto to study nateglinide in combination with DPP IV inhibitor

Oct. 10, 2012

AstraZeneca and Ardelyx sign licensing deal for NHE-3 inhibitor program

Oct. 10, 2012

Amarantus and Rainbow BioSciences form joint venture for NuroPro test

Oct. 10, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...